eConsent for haemodialysis: impact on the patient experience

Not Applicable

• Conditions: End stage kidney disease; Haemodialysis; Informed consent; Public Health - Health service research; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12622001354774
• Lead Sponsor: Pedro Henrique Franca Gois

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-10-21
• Last Update Posted: 6 November 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 244

Inclusion Criteria

All consecutive incident haemodialysis patients will receive information about the study and be invited to participate. Prevalent haemodialysis patients, who have not been consented in the last 12 months, will also be invited to participate. Those that agree will be required to sign written informed consent to proceed into the study.

Exclusion Criteria

< 18 years of age.
Individuals not competent to consent or refuse to consent to medical treatment.
Legally blindness (defined as having corrected acuity of no better than 6/60 and/or a vision field of no more than 10 degrees).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decision regret (assessed by a validated decision regret scale) [ Data collection will occur at informed consent and after 12 months of HD treatments.]